We have shown that known SRSF3 target genes are altered in NAFLD, NASH and HCC suggesting that SRSF3 splicing function is reduced but that remains to be demonstrated for other factors. Here, SRSF3 is linked to metabolic dysfunction-associated steatotic liver disease.